Intermittent Pneumatic Compression Devices
Gravity Suits
Popliteal Vein
Stockings, Compression
Pressure
Femoral Vein
Foot
Equipment and Supplies
Venous Thromboembolism
Heparin, Low-Molecular-Weight
Ultrasonography, Doppler, Duplex
Blood Flow Velocity
Sphygmomanometers
Can a new design of pneumatic compression device reduce variations in delivered therapy for the mechanical prophylaxis of thromboembolic disease after total hip arthroplasty? (1/72)
BACKGROUND: Compression devices have been shown to prevent thromboembolic disease. However, the pressures generated may not be the same as the ones recommended by the manufacturer. The purpose of this study is to investigate a new sequential compression device with feedback to maintain optimal therapy, and to determine whether therapy is improved with this new device. PATIENTS AND METHOD: A series of 50 patients undergoing elective total hip arthroplasty at a major tertiary-care hospital with a special interest in joint replacement were enrolled prospectively. In addition to pharmacological prophylaxis for thromboembolic disease, all patients received compression from a modified device. Maximum pressures generated and the rate of pressure rise in each of the 3 compartments within the device sleeves were measured and the results compared with data from historical controls. RESULTS: We considered therapy to be ideal when in a particular compression cycle all chambers of both right and left sleeves reach within 10% of their target pressures at within 10% of their target pressure rise rates. The average patient received this ideal therapy 88% of the time that the new trial sequential compression device was operating. This represents a dramatic improvement over previous devices. CONCLUSIONS: The new device allows dramatically improved pressures within the device because of a feedback loop that allows dynamic control of each chamber's pressure. Improved consistency of delivery should make it easier to accurately assess the true benefits of mechanical prophylaxis with a sequential compression device. (+info)Effect of intermittent pneumatic compression of foot and calf on walking distance, hemodynamics, and quality of life in patients with arterial claudication: a prospective randomized controlled study with 1-year follow-up. (2/72)
SUMMARY BACKGROUND DATA: Perioperative mortality, graft failure, and angioplasty limitations militate against active intervention for claudication. With the exception of exercise programs, conservative treatments yield modest results. Intermittent pneumatic compression [IPC] of the foot used daily for 3 months enhances the walking ability and pressure indices of claudicants. Although IPC applied to the foot and calf together [IPCfoot+calf] is hemodynamically superior to IPC of the foot, its clinical effects in claudicants remain undetermined. OBJECTIVE: This prospective randomized controlled study evaluates the effects of IPCfoot+calf on the walking ability, peripheral hemodynamics, and quality of life [QOL] in patients with arterial claudication. METHODS: Forty-one stable claudicants, meeting stringent inclusion and exclusion criteria, were randomized to receive either IPCfoot+calf and aspirin[75 mg] (Group 1; n = 20), or aspirin[75 mg] alone (Group 2; n = 21), with stratification for diabetes and smoking. Groups matched for age, sex, initial [ICD] and absolute [ACD] claudication distances, pressure indices [ABI], popliteal artery flow, and QOL with the short-form 36 Health Survey Questionnaire (SF-36). IPCfoot+calf (120 mm Hg, inflation 4 seconds x 3 impulses per minute, calf inflate delay 1 second) was used for 5 months, > or =2.5 hours daily. Both groups were advised to exercise unsupervised. Evaluation of patients, after randomization, included the ICD and ACD, ABI, popliteal artery flow with duplex and QOL* at baseline*, 1/12, 2/12, 3/12, 4/12, 5/12* and 17/12. Logbooks allowed compliance control. Wilcoxon and Mann-Whitney corrected[Bonferroni] tests were used. RESULTS: At 5/12 median ICD, ACD, resting and postexercise ABI had increased by 197%, 212%, 17%, and 64%, respectively, in Group 1 (P < 0.001), but had changed little (P > 0.1) in Group 2; Group 1 had better ICD, ACD, and resting and postexercise ABI (P < 0.01) than Group 2. Inter- and intragroup popliteal flow differences at 5/12 were small (P > 0.1). QOL had improved significantly in Group 1 but not in Group 2; QOL in the former was better (P < 0.01) than in Group 2. QOL in Group 1 was better (P < 0.01) than in Group 2 at 5/12. IPC was complication free. IPC compliance (> or =2.5 hours/d) was >82% at 1 month and >85% at 3 and 5 months. ABI and walking benefits in Group 1 were maintained a year after cessation of IPC treatment. CONCLUSIONS: IPCfoot+calf emerged as an effective, high-compliance, complication-free method for improving the walking ability and pressure indices in stable claudication, with a durable outcome. These changes were associated with a significant improvement in all aspects of QOL evaluated with the SF-36. Despite some limited benefit noted in some individuals, unsupervised exercise had a nonsignificant impact overall. (+info)Rapid foot and calf compression increases walking distance in patients with intermittent claudication: results of a randomized study. (3/72)
OBJECTIVE: The aim of our pilot study was to determine the usefulness of rapid, high-pressure, intermittent pneumatic calf and foot compression (IPCFC) in patients with stable intermittent claudication, with reference to the end points of improvement in initial claudication distance (ICD) (distance at which patient feels pain or discomfort in the legs), and improvement in absolute claudication distance (ACD) (distance at which patient stops walking because the pain or discomfort becomes severe). METHODS: Thirty male patients presenting with stable, intermittent claudication (ACD between 50 and 150 meters on treadmill testing at 3.8 km/h, 10 degrees gradient) were recruited into this pilot study from a single center. Fifteen patients were randomized to treatment with IPCFC (applied for 1 hour twice daily in the sitting position) and were also advised to have daily exercise, and 15 patients served as controls, who were advised exercise alone. All patients received aspirin and had resting and postexercise ankle/brachial index (ABI) measured at enrollment along with ICD and ACD on treadmill testing (3.8 km/h, 10 degrees gradient). The mean age, baseline ICD, and ACD of the treatment and control groups were 70.4 +/- 7 years and 70.7 +/- 9 years, 55.8 +/- 15 meters and 68.4 +/- 17 meters, and 86.7 +/- 19 meters and 103.9 +/- 27 meters, respectively. Both groups were equally matched for risk factors, including smoking, type II diabetes mellitus, and hypercholesterolemia. IPCFC was applied. The study protocol included follow-up visits at 1, 2, 3, 4, 6, and 12 months with the ABI, ICD and ACD being measured at every visit. RESULTS: The percent change from baseline for ICD and ACD for each patient visit and the mean +/- standard deviation (SD), standard error (SE), and median were calculated for the control and treatment groups. The percent change from baseline measurements (mean +/- SD) for ICD and ACD in the control group at 4, 6, and 12 months were 2.2 +/- 18 and 2.3 +/- 18, 2.9 +/- 17 and 5.2 +/- 20, and 3.6 +/- 18 and 5.8 +/- 20, respectively. In contrast, the changes in ICD and ACD at 4, 6, and 12 months in the treatment group were 137.1 +/- 128 (P < .01) and 84.3 +/- 82 (P < .01), 140.6 +/- 127 (P < .01) and 96.4 +/- 106 (P = .01), and 150.8 +/- 124 (P <0.01) and 101.2 +/- 104 (P <0.01), respectively. Although the ABI showed a slight increase in the treatment group, these differences were not statistically significant. CONCLUSIONS: The results of this pilot study show that IPCFC improves walking distance in patients with stable intermittent claudication. A significant increase in ICD and ACD was seen at 4 and 6 months of treatment, respectively, and the improvement was sustained at 1 year. The combination of IPCFC with other treatment such as risk-factor modification and daily exercise may prove useful in patients with peripheral arterial occlusive disease. It may be a useful first line of therapy in patients with disabling claudication who are unfit for major reconstructive surgery. Improved walking on long-term follow-up and experience from different centers may establish a role for this treatment modality in the future. (+info)The efficacy of a new portable sequential compression device (SCD Express) in preventing venous stasis. (4/72)
OBJECTIVE: It has been previously shown that the SCD Response Compression System, by sensing the postcompression refill time of the lower limbs, delivers more compression cycles over time, resulting in as much as a 76% increase in the total volume of blood expelled per hour. Extended indications for pneumatic compression have necessitated the introduction of portable devices. The aim of our study was to test the hemodynamic effectiveness of a new portable sequential compression system (the SCD Express), which has the ability to detect the individual refill time of the two lower limbs separately. METHODS: This was an open, controlled trial with 30 normal volunteers. The new SCD Express was compared with the SCD Response Compression System in the supine and semirecumbent positions. The refilling time sensed by the device was compared with that determined from velocity recordings of the superficial femoral vein using duplex ultrasonography. Baseline and augmented flow velocity and volume flow, including the total volume of blood expelled per hour during compression with the SCD Express, were compared with those produced by the SCD Response compression system in the same volunteers and positions. RESULTS: Both devices significantly increased venous flow velocity as much as 2.26 times baseline in supine position and 2.67 times baseline in semirecumbent position (all P < .001). There was a linear relationship between duplex ultrasonography-derived refill time and the SCD Express-derived refill time in both the supine (r = 0.39, P = .03) and semirecumbent (r = 0.71, P < .001) positions but not with the SCD Response. Refill time measured by the SCD Express device was significantly shorter and the cycle rate higher in comparison with the SCD Response in both positions. The single-cycle flow velocity and volume flow parameters generated by the two devices were similar in both positions. However, median (interquartile range) total volume of blood expelled per hour was slightly higher with the SCD Express device in the supine position (7206 mL/h [range, 5042-8437] vs 6712 mL/h [4941-10,676]; P = .85) and semirecumbent position (4588 mL/h [range, 3721-6252] vs 4262 mL/h [3520-5831]; P = .22). Peak volume of blood expelled per hour by the SCD Express device in the semirecumbent position was significantly increased by 10% in comparison with the SCD Response (P = .03). CONCLUSIONS: Flow velocity and volume flow enhancement by the SCD Response and SCD Express were essentially similar. The latter, a portable device with optional battery power that detects the individual refill time of the lower limbs separately, is anticipated to be associated with improved overall compliance and therefore optimized thromboprophylaxis. Studies testing its potential for improved efficacy in preventing deep vein thrombosis are justified. (+info)Hemodynamic effects of intermittent pneumatic compression in patients with critical limb ischemia. (5/72)
BACKGROUND: Traditional teaching assumes that the distal arterial tree is maximally dilated in patients with critical limb ischemia (CLI). Endovascular or arterial bypass procedures are the commonly used interventions to increase distal perfusion. However, other forms of treatment such as spinal cord stimulation or intermittent pneumatic compression (IPC) have been shown to improve limb salvage rates. This prospective study was designed to determine if the use of IPC increases popliteal, gastrocnemial, collateral arterial, and skin blood flow in patients with CLI. METHODS: Twenty limbs with CLI in 20 patients (mean age, 74 years) were evaluated with duplex ultrasound scans and laser Doppler fluxmetry in the semi-erect position before, during, and after IPC. One pneumatic cuff was applied on the foot and the other on the calf. The maximum inflation pressure was 120 mm Hg and was applied for 3 seconds at three cycles per minute. All patients had at least two-level disease by arteriography. Fourteen limbs were characterized as inoperable, and six were considered marginal for reconstruction. Flow volumes were measured in the popliteal, medial gastrocnemial, and a genicular collateral artery. Skin blood flux was measured on the dorsum of the foot at the same time. RESULTS: Significant flow increase during the application of IPC was found in all three arteries (18/20 limbs) compared with baseline values (P < .02). The highest change was seen in the popliteal, followed by the gastrocnemial and the collateral artery. After the cessation of IPC, the flow returned to baseline. This was attributed to the elevation of time average velocity, as the diameter of the arteries remained unchanged. The skin blood flux increased significantly as well (P < .03). In the two limbs without an increase in the arterial or skin blood flow, significant popliteal vein reflux was found. Both limbs were amputated shortly after. CONCLUSIONS: IPC increases axial, muscular, collateral, and skin blood flow in patients with CLI and may be beneficial to those who are not candidates for revascularization. Patients with significant venous reflux may not benefit from IPC. This supports the theory that one of the mechanisms by which IPC enhances flow is by increasing the arteriovenous pressure gradient. (+info)Duration and amplitude decay of acute arterial leg inflow enhancement with intermittent pneumatic leg compression: an insight into the implicated physiologic mechanisms. (6/72)
PURPOSE: By acutely enhancing the arterial leg inflow, intermittent pneumatic leg compression (IPC) improves the walking ability, arterial hemodynamics, and quality of life of claudicants. We quantified the duration of acute leg inflow enhancement with IPC of the foot (IPC(foot)), calf (IPC(calf)), or both (IPC(foot+calf)) and its amplitude decay in claudicants and controls in relation to the pulsatility index, an estimate of peripheral resistance. These findings are cross-correlated with the features of the three implicated physiologic mechanisms: (1) an increase in the arteriovenous pressure gradient, (2) suspension of peripheral sympathetic autoregulation, and (3) enhanced release of nitric oxide with flow and shear-stress increase. METHODS: Twenty-six limbs of 24 claudicants with superficial femoral artery occlusion or stenoses (>75%) and 24 limbs of 20 healthy controls matched for age and sex, meeting stringent selection criteria, had their popliteal volume flow and pulsating index (peak-to-peak velocity/mean velocity) measured with duplex scanning at rest and upon delivery of IPC. Spectral waveforms were analyzed for 50 seconds after IPC delivery per 5-second segments. The three IPC modes were applied in a true crossover design. Data analysis was performed with the Page, Friedman, Wilcoxon, Mann-Whitney and chi2 tests. RESULTS: The median duration of flow enhancement in claudicants exceeded 50 seconds with IPC(foot), IPC(calf), and IPC(foot+calf) but was shorter (P < .001) in the controls (32.5 to 40 seconds). Among the three IPC modes, the duration of flow enhancement differed (P < .05) only between IPC(foot) and IPC(foot+calf). After reaching its peak within 5 seconds of IPC, flow enhancement decayed at rates decreasing over time (trend, P < .05, Page test), which in both groups were highest at 5 to 20 seconds, moderate at 20 to 35 seconds, and lowest at 35 to 50 seconds (P < .05, Friedman test). Baseline and peak flow with all IPC modes was similar between the two groups. Pulsatility index attenuation in claudicating limbs lasted a median 32.5 seconds with IPC(foot), 37.5 seconds with IPC(calf), and 40 seconds with IPC(foot+calf); duration of pulsatility index attenuation was shorter in the control limbs with IPC(foot) (30 seconds), IPC(calf) (32.5 seconds), or IPC(foot+calf) (35 seconds), yet differences, as well as those among the 3 IPC modes, were not significant. CONCLUSION: Leg inflow enhancement with IPC exceeds 50 seconds in claudicants and lasts 32.5 to 40 seconds in the controls. Peak flow occurs concurrently with maximal pulsatility index attenuation, within 5 seconds of IPC. Irrespective of group or IPC mode, the decay rate (%) of flow enhancement is highest within 5 to 20 seconds of IPC, moderate at 20 to 35 seconds, and lowest at 35 to 50 seconds. Since attenuation in peripheral resistance terminates with the mid time period (20 to 35 seconds) of flow decay, and nitric oxide has a half-life of <7 to 10 seconds, the study's data indicate that all implicated physiologic mechanisms (1, 2, and 3) are likely active immediately after IPC delivery (0 to 20 sec) and all but nitric oxide are effective in the mid time period (20 to 35 seconds). As the pulsatility index has returned to baseline, the late phase of flow enhancement (35 to 50 seconds) could be attributable to the declining arteriovenous pressure gradient alone. (+info)Intermittent pneumatic compression of the foot and calf improves the outcome of catheter-directed thrombolysis using low-dose urokinase in patients with acute proximal venous thrombosis of the leg. (7/72)
OBJECTIVE: Catheter-directed thrombolysis (CDT) is a promising treatment of acute proximal deep vein thrombosis (DVT) to prevent the postthrombotic syndrome by early removal of thrombus. During CDT for DVT patients, the calf muscle pump is compromised because of immobility. Intermittent pneumatic compression (IPC) can be used to increase venous flow during bed rest. The CDT with IPC may lyse venous thrombus better than CDT alone. The purpose of this study was to evaluate the efficiency and safety of IPC during CDT for DVT using low-dose urokinase. METHODS: Twenty-four patients with proximal DVT confirmed by duplex ultrasonography underwent CDT alone (10 cases) and CDT with IPC and a temporary inferior vena cava filter (14 cases) for 3 to 6 days. Pulmonary emboli (PEs) were assessed by pretreatment and posttreatment pulmonary angiogram or spiral computed tomography of the chest, and in the CDT/IPC patients, a posttreatment inferior vena cavogram was performed. The initial results were evaluated by venogram immediately after CDT, and the late results were evaluated by venous disability score and duplex ultrasonography 6 to 36 months after treatment. RESULTS: There was no symptomatic PE in either group. In CDT with IPC, one new asymptomatic PE was found, but there was no large thrombus in the inferior vena cava. The initial thrombolytic results of CDT with IPC were better than those of CDT alone (five cases of complete lysis in the CDT/IPC group and none in the CDT alone group). In the follow-up, the deep veins were patent and competent in 43% (6/14) in the CDT/IPC group, compared with 17% (1/6) in the CDT-alone group. The venous disability score showed that the CDT/IPC group had less disability than the CDT-alone group. CONCLUSIONS: This pilot study showed that adding IPC to CDT using low-dose urokinase for DVT treatment of the leg resulted in better early and late outcomes compared with CDT alone and was not associated with an increased risk of symptomatic PEs. (+info)Compression with or without early ambulation in the prevention of post-thrombotic syndrome: a systematic review. (8/72)
INTRODUCTION: The aim of this study was to assess whether there is enough evidence to suggest that compression with or without early ambulation after proximal DVT reduces the risk of post-thrombotic syndrome (PTS). METHODS: Systematic review based on electronic and hand searching of the relevant literature. RESULTS: Four randomized studies were identified and despite the fact that there was lack of uniformity in reporting standards all but one showed significant risk reduction of PTS using compression. No difference in recurrent thromboembolic events (DVT or pulmonary embolism) was observed between the compression and control group. In one study the early outcome from the combination of early ambulation with compression was faster reduction of swelling with better well-being without increased risk of PE compared to the control group. Pooled analysis of all studies showed that PTS developed in 24% (61/254) in the compression group and in 46% (110/239) in the control group (chi2=25.36, p=0.0001; OR: 0.37, 95%CI: 0.25, 0.54; RR: 0.52, 95%CI: 0.40, 0.67; and RRR: 0.48, 95%CI: 0.33, 0.60) with a 48% risk reduction from the use of compression. CONCLUSION: Despite the fact that compression with or without early ambulation appears to be safe and it is more often associated with a decreased rate of PTS, the four existing studies do not permit meaningful data comparison due to lack of uniformity in reporting standards. (+info)Intermittent Pneumatic Compression (IPC) devices are medical devices that use inflatable garments to apply controlled pressure in a rhythmic, intermittent manner to the extremities of the body, most commonly used on the legs. These devices are designed to help improve venous and lymphatic flow, reduce edema (swelling), and prevent the formation of blood clots (deep vein thrombosis) in patients who are at risk.
The IPC device typically consists of a pump, hoses, and an air-filled garment that covers the affected limb. The pump regulates the pressure and inflation pattern, while the garment applies pressure to the limb. The compression cycle usually starts with low pressure and gradually increases to a peak pressure before decreasing again. This process is repeated at regular intervals, providing intermittent compression that mimics natural muscle contractions and helps promote blood flow.
IPC devices are often used in clinical settings such as hospitals and rehabilitation centers, but they can also be prescribed for home use. They are commonly recommended for patients who have undergone surgery, experienced trauma, or have conditions that increase their risk of developing blood clots, such as prolonged immobilization, varicose veins, or certain medical disorders.
It is essential to follow the healthcare provider's instructions when using IPC devices and report any discomfort, pain, or unusual symptoms during treatment.
"Gravity suits" is not a recognized medical term. However, in the context of space medicine and space travel, gravity suits, also known as g-suits or anti-G suits, are specialized garments worn by pilots and astronauts to prevent or reduce the negative effects of high gravitational forces (G-forces) on their bodies during high-speed maneuvers or while re-entering the Earth's atmosphere.
These suits work by applying pressure to specific areas of the body, typically around the lower abdomen and legs, to prevent the pooling of blood in those areas due to the increased G-forces. This helps maintain adequate blood flow to the brain and other vital organs, reducing the risk of loss of consciousness (G-induced Loss of Consciousness or G-LOC) and other symptoms associated with high G-forces such as blackouts, vision impairment, and disorientation.
It's important to note that gravity suits are not used as a medical treatment for any specific condition but rather as a protective measure during space travel and high-performance aviation.
A bandage is a medical dressing or covering applied to a wound, injury, or sore with the intention of promoting healing or preventing infection. Bandages can be made of a variety of materials such as gauze, cotton, elastic, or adhesive tape and come in different sizes and shapes to accommodate various body parts. They can also have additional features like fasteners, non-slip surfaces, or transparent windows for monitoring the condition of the wound.
Bandages serve several purposes, including:
1. Absorbing drainage or exudate from the wound
2. Protecting the wound from external contaminants and bacteria
3. Securing other medical devices such as catheters or splints in place
4. Reducing swelling or promoting immobilization of the affected area
5. Providing compression to control bleeding or prevent fluid accumulation
6. Relieving pain by reducing pressure on sensitive nerves or structures.
Proper application and care of bandages are essential for effective wound healing and prevention of complications such as infection or delayed recovery.
The popliteal vein is the continuation of the tibial and fibular (or anterior and posterior tibial) veins, forming in the lower leg's back portion or popliteal fossa. It carries blood from the leg towards the heart. The popliteal vein is located deep within the body and is accompanied by the popliteal artery, which supplies oxygenated blood to the lower leg. This venous structure is a crucial part of the venous system in the lower extremities and is often assessed during physical examinations for signs of venous insufficiency or deep vein thrombosis (DVT).
Venous thrombosis is a medical condition characterized by the formation of a blood clot (thrombus) in the deep veins, often in the legs (deep vein thrombosis or DVT), but it can also occur in other parts of the body such as the arms, pelvis, or lungs (pulmonary embolism).
The formation of a venous thrombus can be caused by various factors, including injury to the blood vessel wall, changes in blood flow, and alterations in the composition of the blood. These factors can lead to the activation of clotting factors and platelets, which can result in the formation of a clot that blocks the vein.
Symptoms of venous thrombosis may include swelling, pain, warmth, and redness in the affected area. In some cases, the clot can dislodge and travel to other parts of the body, causing potentially life-threatening complications such as pulmonary embolism.
Risk factors for venous thrombosis include advanced age, obesity, smoking, pregnancy, use of hormonal contraceptives or hormone replacement therapy, cancer, recent surgery or trauma, prolonged immobility, and a history of previous venous thromboembolism. Treatment typically involves the use of anticoagulant medications to prevent further clotting and dissolve existing clots.
Compression stockings are a specialized type of hosiery that applies pressure to your legs, promoting better blood flow. They are tightest at the ankle and gradually become less constrictive up the leg. This gradient compression helps to counteract the force of gravity and promote venous return, reducing the pooling of blood in the lower extremities.
Compression stockings are often used to help prevent or treat various conditions related to poor circulation, including:
1. Varicose veins: Enlarged, swollen, and twisting veins that are easily visible just under the surface of the skin.
2. Deep vein thrombosis (DVT): A blood clot that forms in the deep veins, usually in the legs. Compression stockings can help reduce the risk of DVT after certain surgeries or during long periods of immobilization.
3. Edema: Swelling in the legs and ankles due to fluid buildup.
4. Chronic venous insufficiency: A condition where the veins have difficulty returning blood from the legs back to the heart, leading to symptoms like leg pain, swelling, and skin changes.
5. Post-thrombotic syndrome (PTS): A long-term complication of DVT characterized by chronic leg pain, swelling, and skin ulcers. Compression stockings can help manage symptoms and prevent further complications.
There are different levels of compression available, ranging from mild (15-20 mmHg) to extra firm (50-60 mmHg). Your healthcare provider will recommend the appropriate level based on your specific condition and needs. It is essential to wear compression stockings correctly for them to be effective and avoid skin irritation or other complications.
In medical terms, pressure is defined as the force applied per unit area on an object or body surface. It is often measured in millimeters of mercury (mmHg) in clinical settings. For example, blood pressure is the force exerted by circulating blood on the walls of the arteries and is recorded as two numbers: systolic pressure (when the heart beats and pushes blood out) and diastolic pressure (when the heart rests between beats).
Pressure can also refer to the pressure exerted on a wound or incision to help control bleeding, or the pressure inside the skull or spinal canal. High or low pressure in different body systems can indicate various medical conditions and require appropriate treatment.
In medical terms, the leg refers to the lower portion of the human body that extends from the knee down to the foot. It includes the thigh (femur), lower leg (tibia and fibula), foot, and ankle. The leg is primarily responsible for supporting the body's weight and enabling movements such as standing, walking, running, and jumping.
The leg contains several important structures, including bones, muscles, tendons, ligaments, blood vessels, nerves, and joints. These structures work together to provide stability, support, and mobility to the lower extremity. Common medical conditions that can affect the leg include fractures, sprains, strains, infections, peripheral artery disease, and neurological disorders.
The femoral vein is the large vein that runs through the thigh and carries oxygen-depleted blood from the lower limbs back to the heart. It is located in the femoral triangle, along with the femoral artery and nerve. The femoral vein begins at the knee as the popliteal vein, which then joins with the deep vein of the thigh to form the femoral vein. As it moves up the leg, it is joined by several other veins, including the great saphenous vein, before it becomes the external iliac vein at the inguinal ligament in the groin.
In medical terms, the foot is the part of the lower limb that is distal to the leg and below the ankle, extending from the tarsus to the toes. It is primarily responsible for supporting body weight and facilitating movement through push-off during walking or running. The foot is a complex structure made up of 26 bones, 33 joints, and numerous muscles, tendons, ligaments, and nerves that work together to provide stability, balance, and flexibility. It can be divided into three main parts: the hindfoot, which contains the talus and calcaneus (heel) bones; the midfoot, which includes the navicular, cuboid, and cuneiform bones; and the forefoot, which consists of the metatarsals and phalanges that form the toes.
'Equipment and Supplies' is a term used in the medical field to refer to the physical items and materials needed for medical care, treatment, and procedures. These can include a wide range of items, such as:
* Medical equipment: This includes devices and machines used for diagnostic, monitoring, or therapeutic purposes, such as stethoscopes, blood pressure monitors, EKG machines, ventilators, and infusion pumps.
* Medical supplies: These are consumable items that are used once and then discarded, such as syringes, needles, bandages, gowns, gloves, and face masks.
* Furniture and fixtures: This includes items such as hospital beds, examination tables, chairs, and cabinets that are used to create a functional medical space.
Having the right equipment and supplies is essential for providing safe and effective medical care. The specific items needed will depend on the type of medical practice or facility, as well as the needs of individual patients.
Venous Thromboembolism (VTE) is a medical condition that includes both deep vein thrombosis (DVT) and pulmonary embolism (PE). DVT is a blood clot that forms in the deep veins, usually in the legs, while PE occurs when a clot breaks off and travels to the lungs, blocking a pulmonary artery or one of its branches. This condition can be life-threatening if not diagnosed and treated promptly.
The medical definition of Venous Thromboembolism is:
"The formation of a blood clot (thrombus) in a deep vein, most commonly in the legs, which can then dislodge and travel to the lungs, causing a potentially life-threatening blockage of the pulmonary artery or one of its branches (pulmonary embolism). VTE is a complex disorder resulting from an interplay of genetic and environmental factors that affect the balance between thrombosis and fibrinolysis."
Some common risk factors for VTE include immobility, surgery, trauma, cancer, hormonal therapy, pregnancy, advanced age, and inherited or acquired thrombophilia. Symptoms of DVT may include swelling, pain, warmth, and redness in the affected limb, while symptoms of PE can range from shortness of breath and chest pain to coughing up blood or even sudden death. Diagnosis typically involves a combination of clinical assessment, imaging studies (such as ultrasound, CT scan, or MRI), and laboratory tests (such as D-dimer). Treatment usually includes anticoagulation therapy to prevent further clot formation and reduce the risk of recurrence.
Low-molecular-weight heparin (LMWH) is a type of heparin used as an anticoagulant, which refers to a group of medications that prevent the formation of blood clots. Heparin is a naturally occurring substance in the body, and low-molecular-weight heparins are obtained through the depolymerization of standard heparin.
LMWH has a lower molecular weight than standard heparin, which results in several pharmacological differences. LMWHs have a more predictable dose response, longer half-life, and higher bioavailability when administered subcutaneously compared to standard heparin. They also exhibit greater anti-factor Xa activity relative to their antithrombin (anti-IIa) activity, which contributes to their anticoagulant effects.
LMWHs are used for the prevention and treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), and other thromboembolic disorders. Common LMWHs include enoxaparin, dalteparin, tinzaparin, and nadroparin.
It is essential to monitor the patient's kidney function when using LMWH since they are primarily cleared by the kidneys. In patients with renal impairment, dose adjustments or alternative anticoagulants may be necessary to reduce the risk of bleeding complications.
Ultrasonography, Doppler, and Duplex are diagnostic medical techniques that use sound waves to create images of internal body structures and assess their function. Here are the definitions for each:
1. Ultrasonography: Also known as ultrasound, this is a non-invasive imaging technique that uses high-frequency sound waves to produce images of internal organs and tissues. A small handheld device called a transducer is placed on the skin surface, which emits and receives sound waves. The returning echoes are then processed to create real-time visual images of the internal structures.
2. Doppler: This is a type of ultrasound that measures the velocity and direction of blood flow in the body by analyzing the frequency shift of the reflected sound waves. It can be used to assess blood flow in various parts of the body, such as the heart, arteries, and veins.
3. Duplex: Duplex ultrasonography is a combination of both gray-scale ultrasound and Doppler ultrasound. It provides detailed images of internal structures, as well as information about blood flow velocity and direction. This technique is often used to evaluate conditions such as deep vein thrombosis, carotid artery stenosis, and peripheral arterial disease.
In summary, ultrasonography is a diagnostic imaging technique that uses sound waves to create images of internal structures, Doppler is a type of ultrasound that measures blood flow velocity and direction, and duplex is a combination of both techniques that provides detailed images and information about blood flow.
Blood flow velocity is the speed at which blood travels through a specific part of the vascular system. It is typically measured in units of distance per time, such as centimeters per second (cm/s) or meters per second (m/s). Blood flow velocity can be affected by various factors, including cardiac output, vessel diameter, and viscosity of the blood. Measuring blood flow velocity is important in diagnosing and monitoring various medical conditions, such as heart disease, stroke, and peripheral vascular disease.
A sphygmomanometer is a device used to measure blood pressure. It consists of an inflatable cuff that is wrapped around the upper arm and connected to a column of mercury or aneroid gauge, which measures the pressure in the cuff. The cuff is inflated to occlude the brachial artery, and then gradually deflated while listening for the sounds of the pulsating blood flow with a stethoscope placed over the brachial artery.
The onset of the first sound (systolic pressure) and the disappearance of the last sound (diastolic pressure) are recorded to give an indication of the patient's blood pressure. Digital sphygmomanometers are also available, which use electronic sensors to detect the sounds and provide a digital readout of the blood pressure.
Hemostatic techniques refer to various methods used in medicine to stop bleeding or hemorrhage. The goal of these techniques is to promote the body's natural clotting process and prevent excessive blood loss. Some common hemostatic techniques include:
1. Mechanical compression: Applying pressure directly to the wound to physically compress blood vessels and stop the flow of blood. This can be done manually or with the use of medical devices such as clamps, tourniquets, or compression bandages.
2. Suturing or stapling: Closing a wound with stitches or staples to bring the edges of the wound together and allow the body's natural clotting process to occur.
3. Electrocautery: Using heat generated by an electrical current to seal off blood vessels and stop bleeding.
4. Hemostatic agents: Applying topical substances that promote clotting, such as fibrin glue, collagen, or gelatin sponges, to the wound site.
5. Vascular embolization: Inserting a catheter into a blood vessel and injecting a substance that blocks the flow of blood to a specific area, such as a bleeding tumor or aneurysm.
6. Surgical ligation: Tying off a bleeding blood vessel with suture material during surgery.
7. Arterial or venous repair: Repairing damaged blood vessels through surgical intervention to restore normal blood flow and prevent further bleeding.
Varicose veins
Thrombosis prevention
Postpartum physiological changes
Sepsis
Apex Medical
Andrew Nicolaides
Compression stockings
Intermittent pneumatic compression
RICE (medicine)
Venous ulcer
Deep vein thrombosis
Fuel injection
Vacuum brake
Siphon
Vehicle
Subarachnoid hemorrhage
Starter (engine)
Civil defense siren
Electrical connector
Timeline of Australian inventions
Ford Expedition
Compressor
Nitrous oxide
Glossary of rail transport terms
Intermittent pneumatic compression. A comparison of femoral vein velocity with five different devices - International Angiology...
Intermittent Pneumatic Compression Devices Market by 2028
Thromboembolism Prophylaxis in Gynecologic Surgery: Overview, Epidemiology, Definitions of Risk
PPT) Sequential Compression Devices or SCD's or Intermittent Pneumatic Compression Devices © D. J. McMahon 2014 rev 141102 -...
JCM | Free Full-Text | Therapeutic Alternatives in Diabetic Foot Patients without an Option for Revascularization: A Narrative...
Deep Venous Thrombosis Prophylaxis in Orthopedic Surgery: Background, Mechanical Methods, Pharmacologic Methods
Varicose veins - Wikipedia
Browsing Engineering (Faculty of) by Supervisor "Arami, Arash"
Venous thromboembolism - wikidoc
Thieme E-Journals - Phlebologie / Abstract
2017 Design by Biomedical Undergraduate Teams (DEBUT) Challenge Winners | National Institute of Biomedical Imaging and...
Salpingo-Oophorectomy: Overview, Periprocedural Care, Technique
RFP - Supply of medical devices used in the prevention of venous thromboembolisms - Pharmac | New Zealand Government
VEIN Magazine Podcast | iHeart
Deep Venous Thrombosis (DVT) - Cardiovascular Disorders - Merck Manuals Professional Edition
Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation...
Venous Thromboembolism Prophylaxis in Acutely Ill Hospitalized Medical Patients - McMaster Experts
Sutured for a Living: October 2010
Lymphedema (PDQ®) (Health professionals) | OncoLink
Internal Medicine
Normatec 3 Compression Boot Review | livestrong
Diagnostic And Interventional Radiology
ClotCare: Blood Clots, DVT, PE, Stroke, Coumadin, Warfarin & Anticoagulation Topics
Chronic Venous Insufficiency and Postphlebitic Syndrome - Heart and Blood Vessel Disorders - MSD Manual Consumer Version
compression therapy Archives - ACI MedicalACI Medical
2016 July | Signaling Molecule
Ronin Round Table: Modern Medicine • Green Ronin Publishing
Effectiveness of a novel and scalable clinical decision support intervention to improve venous thromboembolism prophylaxis: a...
Stockings6
- Lifestyle changes may include wearing compression stockings, exercising, elevating the legs, and weight loss. (wikipedia.org)
- Keeping the leg elevated, wearing compression stockings, and carefully treating any wounds are necessary for treatment. (msdmanuals.com)
- In chapter 2 we investigate the effect of light medical elastic compression stockings (light MECS) (Proleg®) on leg symptoms in a choir after a standing rehearsal. (eur.nl)
- In chapter 3 we investigate the use of compression ulcer stockings with regard to reduction of the capillary filtration rate (CFR). (eur.nl)
- In conclusion, compression ulcer stockings are highly effective in reducing the CFR and thus reducing edema formation, which leads to improved healing of venous ulcers. (eur.nl)
- we suggest pharmacologic thromboprophylaxis or mechanical prophylaxis (elastic stockings or intermittent pneumatic compression) in those with contraindications to anticoagulants while in hospital following delivery rather than no prophylaxis" (statements are based on ACCP VTE prevention in nonorthopedic surgical patients guidelines). (bvsalud.org)
Venous10
- New devices should be compared with existing devices to establish whether it has a comparable ability to augment venous velocity. (minervamedica.it)
- Objectives of the study were to compare the venous velocity induced by the Vadoplex with established intermittent pneumatic calf and leg compressors (Covidien and Huntleigh). (minervamedica.it)
- Surprisingly, compression has never been shown to prevent ulcer formation in patients with primary venous insufficiency. (pdfslide.us)
- IPC devices are designed to decrease venous stasis, improve blood flow velocity, and increase the level of circulating fibrinolysins. (medscape.com)
- Intermittent pneumatic compression therapy can be used in chronic venous insufficiency, lymphedema, microangiopathic diseases and in peripheral artery disease. (thieme-connect.de)
- PHARMAC invites proposals for the supply of medical devices used in the prevention of venous thromboembolisms (VTEs) to DHB hospitals in New Zealand. (pharmac.govt.nz)
- PHARMAC is interested in considering any proposal from suppliers of medical devices used in the prevention of venous thromboembolisms (VTEs), such as Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) for use in DHB Hospitals. (pharmac.govt.nz)
- In some cases, compression therapy is used to improve blood flow for people with chronic conditions like venous and lymphatic disease. (livestrong.com)
- Purpose To compare, using Duplex ultrasonography, different intermittent pneumatic compression (IPC) systems to augment venous blood flow for deep venous thrombosis (DVT) prevention during and after surgery and during periods of immobility. (cnyangkun.com)
- Combined intermittent pneumatic leg com pression and pharmacological prophylaxis for prevention of venous thromboembolism. (arjo.com)
Lymphedema3
- The Flexitouch system is an advanced intermittent pneumatic compression device (lymphedema pump) used by tens of thousands of pati. (iheart.com)
- Intermittent pneumatic compression (CPI) is an adjunctive therapy in the management of lymphedema. (centrokinetic.ro)
- CPI devices are an additional tool of a multimodal approach, which can be used as adjunctive therapy in lymphedema management. (centrokinetic.ro)
Prophylaxis3
- Intermittent pneumatic compression was the most common form of medical prophylaxis utilized in the United States, although it was used very rarely in other countries (22% vs 0.2%, respectively). (mcmaster.ca)
- Learn more about mechanical prophylaxis and Intermittent Pneumatic Compression (IPC) with our downloadable summary below. (arjo.com)
- Mechanical prophylaxis uses non-invasive medical devices rather than medication, in VTE prevention. (arjo.com)
Inflation and deflation2
- After several preliminary tests to help define IPC design and device reliability, forty healthy participants were recruited and tested, using different sets of compression pressures and cuff inflation and deflation timing values. (figshare.com)
- IPC works by moving blood from the deeper veins, by the intermittent inflation and deflation of a garment. (arjo.com)
Pharmacologic1
- Early mobilization, intermittent pneumatic compression devices and pharmacologic agents are used to prevent VTE. (signalingmolecule.com)
Therapy13
- therapy, manual lymphatic drainage and external sequential compression devices. (pdfslide.us)
- In this medical education article, the use of intermittent pneumatic compression therapy is demonstrated. (thieme-connect.de)
- Enter Normatec boots - the Normatec 3 compression therapy boots , to be exact. (livestrong.com)
- First, What's Compression Therapy? (livestrong.com)
- There are all sorts of compression therapy tools, including compression socks , bandages and sleeves. (livestrong.com)
- Compression boots like the Normatec 3 are a particular type of therapy called intermittent pneumatic compression (IPC). (livestrong.com)
- The takeaway: Compression therapy is most effective at preventing or managing underlying blood flow or clotting conditions. (livestrong.com)
- Intermittent pneumatic compression therapy is being used to treat patients with ischemic limbs where conventional treatments (namely surgery) fail or cannot be used. (acimedical.com)
- If you are interested in learning more about arterial pneumatic compression pump therapy to treat ischemic ulcers, ACI Medical encourages you to explore the growing research surrounding the ArtAssist® device . (acimedical.com)
- Many doctors, including Mr. Sultan at the Galway Clinic, prescribe ArtAssist® device therapy to patients who are not candidates for surgical intervention. (acimedical.com)
- Compression therapy is the cornerstone in the treatment of CVD, as treatment modality as well as supplement to another treatment. (eur.nl)
- What is compression therapy? (corenewport.com)
- Compression therapy increases blood flow in a given area by applying controlled pressure. (corenewport.com)
Pump1
- An IPC is an intermittent pneumatic compression device that is composed of an inflatable garment consisting of multiple pressure compartments that wraps around the arm or leg, and an electrical pneumatic pump that fills the garment with compressed air. (cnyangkun.com)
Efficacy2
- A new device (Vadoplex) has been developed to provide a short impulse around the calf, a concept derived from the efficacy of foot impulse technology. (minervamedica.it)
- Patient compliance is an issue with IPC devices, and efficacy is dependent on the time of use. (medscape.com)
Sequential4
- Sequential Compression Devices or SCDs or Intermittent Pneumatic Compression Devices D. J. McMahon 2014 rev DVT: Deep Vein Thrombosis - Formation of a blood clot in a deep vein. (pdfslide.us)
- Pitting edema: Sequential compression devices (SCDs) apply a low pressure to a compartmented cuff on the foot or leg. (pdfslide.us)
- Calf or thigh length garments are common, delivering either uniform compression through a single air bladder or sequential compression through a series of air bladders. (arjo.com)
- We recommend that all women undergoing cesarean delivery receive sequential compression devices starting before surgery and that they be continued until the patient is fully ambulatory. (bvsalud.org)
Contraindications1
- How do Intermittent Pneumatic Compression Devices (IPC's) work and what are the Contraindications? (cnyangkun.com)
Abstract1
- Phoenix, AZ - The abstract committee awarded the presentation that monitored ArtAssist device treatment of limb-threatening conditions with fluorescent angiography first prize in the Non-Residency category at the annual Desert Foot meeting that took place from November 18-20, 2015. (acimedical.com)
Lower limb1
- Enhanced muscle blood flow with intermittent pneumatic compression of the lower leg during plantar flexion exercise and recovery.AbstractThe study () tested the hypothesis that intermittent compression of the lower limb would increase blood flow during exercise and post-exercise recovery. (cnyangkun.com)
20204
- As per Growth Market Reports industry analyst Rajas Shirwalkar, "The intermittent pneumatic compression (IPC) devices market is anticipated to witness significant growth during forecast period 2020-2028. (growthmarketreports.com)
- The first quarter of 2020 was an unforeseen turning point for the medical device and healthcare market. (growthmarketreports.com)
- However, after second quadrant due to increasing product demand for home-use IPC devices has boosted market growth in 2020. (growthmarketreports.com)
- Increasing production process owing to government regulation and rising concern for health safety in multiple organizations boosted the use of intermittent pneumatic compression (IPC) devices in 2020. (growthmarketreports.com)
Patients10
- Studies of pneumatic compression in cardiac surgery and neurosurgical patients have shown a distinct improvement in the incidence of DVT without the added risk of bleeding. (medscape.com)
- The device exploits changes observed in the brainwaves of Alzheimer's patients in response to special auditory tones. (nih.gov)
- The ArtAssist® device has been clinically shown to drastically improve circulation in patients with limb-threatening ischemia, a result of advanced peripheral arterial disease (PAD). (acimedical.com)
- In recent years, the ArtAssist® device has entered the market with the claim that patients who cannot undergo surgical revascularization can be spared from major amputation. (acimedical.com)
- Patients use the device at home with a physician's prescription. (acimedical.com)
- The winning presentation covered the use of Novadaq's LUNA™ Fluorescence Angiography with SPYQ technology to monitor the progress of non-operable patients who were treated with the ArtAssist® device to restore arterial blood flow to the limbs. (acimedical.com)
- LUNA™ technology allowed the Madigan AMC research team to visualize the changes in blood flow brought on by the ArtAssist® device with minimal risk to the study patients. (acimedical.com)
- Physical therapists and other sports rehab professionals have actually been using similar devices on their patients for many years. (athleticmuscle.com)
- The Fist Assist device is an intermittent pneumatic compression device focused on vein dilation for Stage 4 and Stage 5 ESRD patients. (medifocusindia.com)
- Empower patients to have a device for vein dilation. (medifocusindia.com)
Calf3
- Pneumatic compression treatment uses calf-high or thigh-high cuffs that alternatively inflate with air and deflate every few minutes automatically to squeeze and massage the veins in legs and ameliorate blood flow. (growthmarketreports.com)
- Various forms of IPC devices are available, and they can be applied to the foot, calf, or thigh. (medscape.com)
- A powered device uses an inflatable calf, thigh length or foot compression garment, to simulate the natural process of walking. (arjo.com)
Sleeves3
- The Normatec 3 are the most intuitive boots the brand has launched yet: Just slide on the sleeves, plug the boots' hoses into the small control unit, select your desired pressure and treatment time and let the device do its thing. (livestrong.com)
- Pneumatic compression sleeves have multiple compartments that are inflated in sequence to facilitate blood flow. (corenewport.com)
- Compression recovery boots are inflated leg sleeves. (athleticmuscle.com)
Chronic1
- Objectives: The shear stress stimulus needed to switch on arteriogenesis, attenuated in chronic limb-threatening ischemia (CLI), can be restored with intermittent pneumatic compression (IPC). (acimedical.com)
Pumps2
- The boots offer seven levels of intensity, delivered to your legs via Normatec's patented Pulse technology, which pumps air into five overlapping zones so all of your muscles get adequate compression. (livestrong.com)
- There are many different devices, pumps and garments when it comes to IPC. (arjo.com)
Ischemia1
- spinal compression and ischemia at T7. (musculoskeletalkey.com)
Mechanical devices2
- Aim: Different mechanical devices for thromboprophylaxis have different flow characteristics. (minervamedica.it)
- The only solution is to offer inexpensive, easily accessible mechanical devices for pneumatic compression (IPC). (cnyangkun.com)
Normatec3
- The Normatec 3 compression boots help relieve tight muscles after an intense workout. (livestrong.com)
- Here's why the Normatec compression boots were a game-changer for my recovery routine, plus whether or not you should try them yourself. (livestrong.com)
- The NormaTec compression recovery boot is one of the most popular recovery boots on the market. (athleticmuscle.com)
Symptoms2
- Upper extremity DVT occasionally occurs as part of superior vena cava (SVC) syndrome (compression or invasion of the superior vena cava by a tumor and causing symptoms such as facial swelling, dilated neck veins, and facial flushing) or results from a hypercoagulable state or subclavian vein compression at the thoracic outlet. (merckmanuals.com)
- Workers tend to underreport the syndrome because symptoms are intermittent and occur most frequently under conditions not present in a doctor's office (e.g., early in the morning or when the hands are cold or wet). (cdc.gov)
Manual lymphati1
- In a way, compression boots work similar to manual lymphatic drainage, which is frequently used by massage therapists and sometimes by physical therapists. (athleticmuscle.com)
Vascular5
- However, due to home isolation and decrease in outdoor mobility many people developed vascular clot diseases, which in turn, increased the demand and use of IPC devices during pandemic. (growthmarketreports.com)
- Intermittent pneumatic compression (IPC) is used in the management of vascular disorders. (uwaterloo.ca)
- Background: Intermittent pneumatic compression (IPC) of legs exerts beneficial local vascular effects, possibly through local release of nitric oxide (NO). However, studies demonstrating systemic transport of nitrogen oxide species and release of NO prompt the question of whether IPC could also exert nonlocal effects. (acimedical.com)
- Furthermore, numerous studies on this device have been published in Vascular and Endovascular Surgery, a peer reviewed medical journal. (acimedical.com)
- Once the anesthetic team have gained good vascular access with the monitoring devices in place the surgical team comes into position, the surgeon often stands on the right side of the patient with the assistant on the left side. (lapguru.com)
Arterial2
- As a pioneering technology, ArtAssist®…The Arterial Assist Device® faces resistance in the medical community at large. (acimedical.com)
- The ArtAssist® device uses a patented rapid compression sequence to stimulate increased arterial blood flow to the limbs. (acimedical.com)
Increases1
- This results in pain and paraesthesia due to increases in pressures along the carpal tunnel region (wrist) which causes compression and inflammation of the median nerve, which is most commonly affected. (corenewport.com)
Medical6
- Medical devices manufacturing was hampered across countries due to the outbreak of COVID-19. (growthmarketreports.com)
- Supply chains were disturbed by COVID-19 outbreaks in major regions, but demand for various medical products including IPC devices were increased, due to health crisis across the globe. (growthmarketreports.com)
- PHARMAC contracts with device suppliers to ensure our hospitals can buy medical devices at fairer prices. (pharmac.govt.nz)
- What is a hospital medical device? (pharmac.govt.nz)
- Fist Assist is a novel, medical device start-up that has developed the first renal care wearable device focused on changing the standard of care of vein dilation by improving outcomes, reducing costs and improving patient compliance for the ESRD market. (medifocusindia.com)
- The Fist Assist® device (US Patent 8231558) is an external medical intermittent pneumatic compression device that can apply intermittent pressure to a specific arm vein that may help dilate the vein after fistula placement. (medifocusindia.com)
Blood7
- Intermittent pneumatic compression (IPC) devices are used to help prevent blood clots in the deep veins of the legs. (growthmarketreports.com)
- Cuffless blood pressure (BP) estimation devices are receiving considerable attention as tools for improving the management of hypertension, a condition that affects 1.13 billion people worldwide. (uwaterloo.ca)
- These devices have also come to the mainstream as a potential tool to support athletic recuperation by increasing blood flow to tired, post-workout legs, thereby speeding up the muscle recovery process. (livestrong.com)
- He was fitted with intermittent pneumatic compression devices for his legs to prevent blood clots, mimicking the effects of walking around for him in case he was weak, dizzy, nauseous, or otherwise couldn't walk for himself for an extended period. (greenronin.com)
- Before and after images of the ulcer showed complete healing and significantly increased blood flow after two weeks of ArtAssist® device treatment. (acimedical.com)
- The device can be used to relieve tissue tension and increase blood flow to the area, which may increase range of motion and aid in soft tissue recovery. (epicpt.com)
- When inflated with air, they provide moderate compression to the legs, which can improve blood flow and lymphatic drainage. (athleticmuscle.com)
Significantly1
- The intermittent pneumatic compression (IPC) devices market is anticipated to grow significantly during forecast period. (growthmarketreports.com)
Garments1
- How Are Compression Bandages, Garments, … 1 How Are Compression Bandages, Garments, Devices and Supplies Coverable under the Social Security Act? (pdfslide.us)
ArtAssist3
- ArtAssist® device treatment was initiated to preserve the limb. (acimedical.com)
- Ultimately, the researchers concluded, the combined treatments of the ArtAssist® device, debridement, offloading, and topical wound care contributed to successful limb preservation. (acimedical.com)
- The team's final note: consider the ArtAssist® device before amputating non-operable limbs. (acimedical.com)
Legs3
- The devices use cuffs around the legs that fill with air and squeeze your legs. (growthmarketreports.com)
- While many compression recovery boots claim that you'll get slimmer legs and softer skin, this isn't exactly what they're all about. (athleticmuscle.com)
- It involves patient positioning on his/her back with both the legs elevated and rested on an assistive device called stirrups. (nurseship.com)
Effect1
- The researchers also noted, however, that these devices didn't have a lasting effect on exercise-induced muscle damage. (livestrong.com)
Surprisingly1
- Surprisingly, in the sports rehab realm, compression recovery boots aren't necessarily a new and upcoming tool. (athleticmuscle.com)
External1
- Common treatments include external static (bandage) and dynamic (Intermittent Pneumatic Compression (IPC)) compression. (figshare.com)
Pressures1
- A novel IPC device was designed and prototyped to provide adjustable parameters (pressures, time), safety, and reliability. (figshare.com)
Pressure2
- Pressure sensors in the device monitor the pressure levels, and a microprocessor controls the applied pressure and the time delays between cycles. (pdfslide.us)
- Pressure can be applied via a compression wrap or a pneumatic device. (corenewport.com)
Early1
- ACOG: "Placement of pneumatic compression devices before cesarean delivery is recommended for all women, and early mobilization is advised after cesarean delivery" (statement is based on one meta-analysis of 60 observational studies and ACCP VTE and pregnancy guidelines). (bvsalud.org)
Active1
- Measurements were taken at rest and on standing, with each device inactive and active. (minervamedica.it)
Lightweight1
- In terms of value, the home use segment is anticipated to expand at a CAGR of 7.1%, during the forecast period, due to growing demand of lightweight and portable IPC devices. (growthmarketreports.com)
Boot1
- Keep on reading to learn more about your compression recovery boot options! (athleticmuscle.com)
Methods1
- There is a global need to provide better vein dilation methods and devices to sufficiently dilate a vein for hemodialysis, help mature fistula, and help ensure that AVF reach their optimal size without extra delay and extra procedures. (medifocusindia.com)
Prevent2
- These compression boots prevent my muscles from being sore and help me bounce back a lot faster than before using them. (livestrong.com)
- Similarly, IPC devices are often used to prevent deep vein thrombosis in people who are inactive while recovering from illness or surgery, per the Cleveland Clinic. (livestrong.com)
Patient1
- intermittent pneumatic compression devices are in place along with a patient warming blanket. (lapguru.com)
Resistance1
- For instance, a small June 2017 study in PLOS One found that using an IPC device after resistance training helped preserve flexibility and reduce oxidative stress on the muscles of 20 people. (livestrong.com)
Knee1
- A study comparing asymmetrical with circumferential IPC devices following total knee replacement (TKR) seemed to support use of the asymmetrical device. (medscape.com)
Market3
- In terms of applications, the global intermittent pneumatic compression (IPC) devices market is bifurcated into home use and hospital. (growthmarketreports.com)
- Certain discrepancies in production and supply chain created mild disruptions across some areas in the supply chain of the intermittent pneumatic compression (IPC) devices market. (growthmarketreports.com)
- The market in Asia Pacific is anticipated to hold a substantial share of the global intermittent pneumatic compression (IPC) device market, owing to the well-developed medtech in the region and presence of established market participants. (growthmarketreports.com)